Literature DB >> 7039525

Intermediate filaments in synovial lining cells in rheumatoid arthritis and other arthritides are of vimentin type.

O A Osung, M Chandra, E J Holborow.   

Abstract

Cryostat section of synovial tissue from patients with rheumatoid arthritis, ankylosing spondylitis, osteoarthrosis, pigmented villonodular synovitis, and from a normal knee were studied by indirect immunofluorescence with guinea-pig antibodies to the intermediate filament proteins prekeratin, vimentin, and desmin. Staining for vimentin, but absence of prekeratin and desmin, was demonstrated in synovial lining cells. Antivimentin antibody also stained synovial tissue fibroblasts and vascular endothelial lining cells. The intensity of fluorescent staining for vimentin broadly correlated with cellular proliferative activity at these 3 sites.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039525      PMCID: PMC1000868          DOI: 10.1136/ard.41.1.74

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  The intermediate-sized filaments in rat kangaroo PtK2 cells. II. Structure and composition of isolated filaments.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Cytobiologie       Date:  1978-08

2.  Oligoclonal immunoglobulins and smooth muscle antibodies in arthritic joints.

Authors:  O J Mellbye; O Fyrand; H K Brath; E Olsen
Journal:  Clin Exp Immunol       Date:  1980-04       Impact factor: 4.330

3.  Ultrastructure of synovial membrane in rheumatoid arthritis.

Authors:  F N Ghadially; S Roy
Journal:  Ann Rheum Dis       Date:  1967-09       Impact factor: 19.103

4.  Studies on the function and composition of the 10-NM(100-A) filaments of vertebrate smooth muscle.

Authors:  J V Small; A Sobieszek
Journal:  J Cell Sci       Date:  1977-02       Impact factor: 5.285

  4 in total
  8 in total

1.  Antibodies to T- and L-isoforms of the cytoskeletal protein, fimbrin, in patients with systemic lupus erythematosus.

Authors:  E C De Mendonca Neto; A Kumar; N A Shadick; A M Michon; P Matsudaira; R B Eaton; P Kumar; P H Schur
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

2.  A novel synoviocyte line (RAMAK-1), derived from a patient with rheumatoid arthritis.

Authors:  M Kawakami; S Matsukuma; M Hara; T Hidaka; K Suzuki; A Kitani; S Hiroi; T Ishizuka; Y Matsuki; H Nakamura
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

3.  Antibodies to cardiolipin and intermediate filaments: a study of autoimmunity in rheumatoid arthritis.

Authors:  R Jacobs; M G Butler; D L Scott
Journal:  Clin Rheumatol       Date:  1990-12       Impact factor: 2.980

4.  Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.

Authors:  R M Hoet; A M Boerbooms; M Arends; D J Ruiter; W J van Venrooij
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

Review 5.  Potential mechanisms for coordinate gene activation in the rheumatoid synoviocyte: implications and hypotheses.

Authors:  C T Ritchlin; R J Winchester
Journal:  Springer Semin Immunopathol       Date:  1989

6.  Synovial sarcoma--a misnomer.

Authors:  M Miettinen; I Virtanen
Journal:  Am J Pathol       Date:  1984-10       Impact factor: 4.307

7.  Expression of CD44 in normal and rheumatoid synovium and cultured synovial fibroblasts.

Authors:  K J Henderson; J C Edwards; J G Worrall
Journal:  Ann Rheum Dis       Date:  1994-11       Impact factor: 19.103

8.  The Predicted Proteomic Network Associated with the Antiarthritic Action of Qingfu Guanjieshu in Collagen-II-Induced Arthritis in Rats.

Authors:  Ting Yu Wang; Hua Zhou; Yuen Fan Wong; Pui Kei Wu; Wen-Luan Wendy Hsiao; Elaine Lai-Han Leung; Liang Liu
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-27       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.